Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 8.780
Filtrar
1.
Recenti Prog Med ; 112(1): 13-14, 2021 01.
Artículo en Italiano | MEDLINE | ID: mdl-33512352

RESUMEN

Informed consent for CoViD-19 vaccines can be considered a step that can help us focus on an increasingly burdensome problem for contemporary medicine: the difficult relationship of trust between citizens and academic medicine. Filling out forms full of useless information cannot replace the rebuilding of trust based on shared essential ethical principles. Trust needs to be protected by a transparent accountability, which can also decrease the threatening looming of lawsuits. Medicine must be safe, first and foremost, for the practitioner. He cannot practice it if he feels constantly in check, if the outcome of the treatment does not correspond to the wishes of those who request it.


Asunto(s)
Consentimiento Informado/psicología , Relaciones Médico-Paciente , Confianza , Negativa a la Vacunación/psicología , Actitud Frente a la Salud , Francia , Humanos , Consentimiento Informado/legislación & jurisprudencia , Italia , Responsabilidad Legal , Opinión Pública , Negativa a la Vacunación/legislación & jurisprudencia
2.
J Urol ; 205(1): 264-270, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-32749908

RESUMEN

PURPOSE: Postoperative opioids are overprescribed in the United States. In November 2016 the State of Pennsylvania required an opioid consent for minors. Our hypothesis is that this mandate decreased postoperative opioid prescriptions in our division. MATERIALS AND METHODS: All patients who received a urological outpatient or minor emergency procedure from August 2015 to August 2019 were identified. Surgeries performed within 6 months after mandate implementation were excluded to account for the transition period. Perioperative data including case type were extracted by a clinical data warehouse from preexisting fields within the health record. The frequencies of postoperative prescriptions, delayed prescriptions and emergency department encounters were assessed. A multivariable logistic regression to identify predictors of opioid prescription at discharge was performed. RESULTS: A total of 4,349 patients were analyzed. The frequency of postsurgical opioid prescriptions decreased from 45.3% to 2.6% (p <0.001). The median morphine milligram equivalent decreased by 22.5 among children prescribed an opioid (p <0.001). Rates of an emergency department visits (3% vs 2.7%) or delayed nonopioid prescriptions (0.8% vs 1.2%) within 30 days of discharge were unchanged (p >0.05). Fewer patients received a delayed opioid prescription after mandate implementation (0.03% vs 0.5%, p <0.001). Female patients were less likely (OR 0.309, 95% CI 0.195-0.491; p <0.001) to receive opioids prior to but not after the mandate (OR 0.309, 95% CI 0.544-2.035; p=0.122). Increasing age was predictive of receiving an opioid before (OR 1.187, 95% CI 1.157-1.218; p <0.001) and after (OR 1.241, 95% CI 1.186-1.299; p <0.001) the mandate. CONCLUSIONS: A state mandated opioid consent for minors greatly reduced post-urological surgery opioid prescription rates without increasing rates of readmission or delayed prescriptions.


Asunto(s)
Analgésicos Opioides/efectos adversos , Consentimiento Informado/legislación & jurisprudencia , Manejo del Dolor/normas , Dolor Postoperatorio/tratamiento farmacológico , Pautas de la Práctica en Medicina/estadística & datos numéricos , Procedimientos Quirúrgicos Urológicos/efectos adversos , Procedimientos Quirúrgicos Ambulatorios/efectos adversos , Analgésicos Opioides/normas , Niño , Preescolar , Utilización de Medicamentos/legislación & jurisprudencia , Utilización de Medicamentos/estadística & datos numéricos , Servicio de Urgencia en Hospital/estadística & datos numéricos , Tratamiento de Urgencia/efectos adversos , Tratamiento de Urgencia/métodos , Femenino , Humanos , Lactante , Consentimiento Informado/normas , Masculino , Epidemia de Opioides/prevención & control , Manejo del Dolor/métodos , Dolor Postoperatorio/etiología , Readmisión del Paciente/estadística & datos numéricos , Pennsylvania , Pautas de la Práctica en Medicina/legislación & jurisprudencia , Pautas de la Práctica en Medicina/normas , Estudios Retrospectivos , Gobierno Estatal , Procedimientos Quirúrgicos Urológicos/métodos , Urólogos/legislación & jurisprudencia , Urólogos/normas , Urólogos/estadística & datos numéricos
3.
Chiropr Man Therap ; 28(1): 60, 2020 11 04.
Artículo en Inglés | MEDLINE | ID: mdl-33148281

RESUMEN

BACKGROUND: The COVID-19 pandemic has seen the emergence of unsubstantiated claims by vertebral subluxation-based chiropractors that spinal manipulative therapy has a role to play in prevention by enhancing the body's immune function. We contend that these claims are unprofessional and demonstrate a disturbing lack of insight into the doctrine of informed consent. As such it is timely to review how informed consent has evolved and continues to do so and also to discuss the attendant implications for contemporary health practitioner practice. We review the origins of informed consent and trace the duty of disclosure and materiality through landmark medical consent cases in four common law (case law) jurisdictions. The duty of disclosure has evolved from a patriarchal exercise to one in which patient autonomy in clinical decision making is paramount. Passing time has seen the duty of disclosure evolve to include non-medical aspects that may influence the delivery of care. We argue that a patient cannot provide valid informed consent for the removal of vertebral subluxation. Further, vertebral subluxation care cannot meet code of conduct standards because it lacks an evidence base and is practitioner-centered. The uptake of the expanded duty of disclosure has been slow and incomplete by practitioners and regulators. The expanded duty of disclosure has implications, both educative and punitive for regulators, chiropractic educators and professional associations. We discuss how practitioners and regulators can be informed by other sources such as consumer law. For regulators, reviewing and updating informed consent requirements is required. For practitioners it may necessitate disclosure of health status, conflict of interest when recommending "inhouse" products, recency of training after attending continuing professional development, practice patterns, personal interests and disciplinary findings. CONCLUSION: Ultimately such matters are informed by the deliberations of the courts. It is our opinion that the duty of a mature profession to critically self-evaluate and respond in the best interests of the patient before these matters arrive in court.


Asunto(s)
Quiropráctica/legislación & jurisprudencia , Revelación/legislación & jurisprudencia , Consentimiento Informado/legislación & jurisprudencia , Pandemias/legislación & jurisprudencia , Betacoronavirus , Infecciones por Coronavirus , Humanos , Neumonía Viral
4.
S Afr Med J ; 110(10): 993-994, 2020 08 21.
Artículo en Inglés | MEDLINE | ID: mdl-33205726

RESUMEN

It has recently been suggested that ethically and legally the obtaining of biological samples for research after death during the COVID-19 pandemic in South Africa justifies a waiver of consent followed by a deferred proxy consent. However, it is submitted that because deceased persons are not protected by the Constitution, and only partially protected by common law and statute law, such consent and the need for consent to autopsies may be dispensed with altogether under the common law doctrine of 'necessity'. It is pointed out that such information is in the public interest because it will inform critical care facilities on how to save lives of future patients and assist government in responding to the COVID-19 pandemic by adequate planning. It is also reasonably justifiable in the public interest to ascertain the COVID-19 status of deceased persons who may have been exposed to the virus, in order to protect their family, friends, healthcare practitioners, undertakers and staff members, and members of the public with whom they have been in contact. Finally, it is suggested that the law can be clarified by amending the Disaster Management COVID-19 regulations to do away with consent for such autopsies or tissue sample collections from deceased persons exposed to the risk of contracting the virus, subject to certain conditions.


Asunto(s)
Directivas Anticipadas/legislación & jurisprudencia , Autopsia , Infecciones por Coronavirus/mortalidad , Consentimiento Informado/legislación & jurisprudencia , Pandemias/legislación & jurisprudencia , Neumonía Viral/mortalidad , Betacoronavirus , Humanos , Sudáfrica
5.
Clin Ter ; 171(5): e401-e406, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32901782

RESUMEN

INTRODUCTION: The study in question starts from a general analysis of Law n. 219/2017 and then to deepen the patient's right to self-determination, which is exercised through the expression of an informed consent to medical therapy. The analysis refers in particular to the patient's decision-making autonomy, the professional autonomy of the doctor and his consequent responsibility. MATERIALS AND METHODS: This study examines the art. 5 of the Law n. 219/2017, where the Legislator has defined the theme of shared planning of care. The authors compare the Advance Treatment Provisions (Article 4 - Law No. 219/2017) and the Shared Care Planning, to then examine the emerging relationship of care between doctor and patient. RESULT: The relationship of care must be related to the patient's willingness to decide on his future and to the technical and scientific information that the doctor is required to give. CONCLUSION: In conclusion, the Authors highlight the innovative content of the shared care plan, emphasizing the importance for a patient suffering from a chronic and progressive disease to be actively involved in formulating their own therapeutic plan.


Asunto(s)
Consentimiento Informado/legislación & jurisprudencia , Derechos del Paciente/legislación & jurisprudencia , Humanos , Italia , Manejo de Atención al Paciente , Participación del Paciente , Autonomía Personal
7.
Pediatrics ; 146(Suppl 1): S18-S24, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32737228

RESUMEN

With a few notable exceptions, adolescents do not possess the legal authority to provide consent for or refuse medical interventions. However, in some situations, the question arises regarding whether a mature minor should be permitted to make a life-altering medical decision that would be challenged if made by the minor's parent. In this article, I explore what we currently know about the adolescent brain and how that knowledge should frame our understanding of adolescent decision-making. The prevailing approach to determining when adolescents should have their decisions respected in the medical and legal context, an approach that is focused on establishing capacity under a traditional informed consent model, will be reviewed and critiqued. I will suggest that the traditional model is insufficient and explore the implications for the adolescent role in health care decision-making.


Asunto(s)
Desarrollo del Adolescente , Encéfalo/crecimiento & desarrollo , Toma de Decisiones Clínicas , Enfermedad de Hodgkin/tratamiento farmacológico , Consentimiento Informado/psicología , Negativa del Paciente al Tratamiento/psicología , Adolescente , Conducta del Adolescente/psicología , Factores de Edad , Femenino , Humanos , Consentimiento Informado/legislación & jurisprudencia , Competencia Mental/legislación & jurisprudencia , Competencia Mental/psicología , Madres , Patient Self-Determination Act , Autonomía Personal , Negativa del Paciente al Tratamiento/legislación & jurisprudencia , Estados Unidos
8.
Rev. bioét. derecho ; (49): 155-171, jul. 2020.
Artículo en Portugués | IBECS | ID: ibc-192100

RESUMEN

Este artigo debate as inovações trazidas com o Código Civil e Comercial argentino, junto a um paralelo com o Estatuto da Pessoa com Deficiência no Brasil, cujas leis se adequaram à Convenção de Nova York de 2006. A pesquisa partiu da análise de documentos normativos e autores de direito civil e bioética, de forma a questionar como se efetivará a manifestação de vontade dos doentes mentais na relação médico-paciente. Para tanto, será abordado inicialmente quais mudanças ocorreram na capacidade civil no ordenamento jurídico argentino. Após, discutir-se-á a relação entre autonomia e competência e sua configuração na relação médico-paciente, para após adentrar-se no consentimento dos doentes mentais. Por fim, comparar-se-á o tratamento dado a tais indivíduos com dois países


Este artículo analiza las innovaciones del Código Civil y Comercial argentino, haciendo un paralelo con el Estatuto de la Persona con Discapacidad en Brasil, cuyas leyes se adecuaron a la Convención de Nueva York de 2006. La investigación partió del análisis de documentos normativos y autores de derecho civil y bioética, para cuestionar cómo se efectúa la manifestación de voluntad de los enfermos mentales en la relación médico-paciente. Para ello, se abordará qué cambios ocurrieron en la capacidad civil en el ordenamiento jurídico argentino. Luego se discutirá la relación entre autonomía y competencia y su configuración en la relación médico-paciente, para después adentrarse en el consentimiento de los enfermos mentales. Por último, se comparará el tratamiento dado a tales individuos en ambos países


This article discusses the innovations brought with the Argentine Civil and Commercial Code, along with a parallel with the Statute of the Person with Disabilities in Brazil, whose laws were in line with the New York Convention of 2006. The research was based on the analysis of documents normative and authors of civil law and bioethics, in order to question how the manifestation of will of the mentally ill in the doctor-patient relationship will take place. To do so, it will be initially addressed what changes have occurred in civil capacity in the Argentine legal system. Afterwards, the relationship between autonomy and competence and its configuration in the doctor-patient relationship will be discussed, after entering into the consent of the mentally ill. Finally, the treatment given to such individuals with two countries will be compared


Aquest article analitza les innovacions del Codi Civil I Comercial argentí, fent un paral·lel amb l'Estatut de la Persona amb Discapacitat al Brasil, les lleis del qual es van adequar a la Convenció de Nova York de 2006. La investigació va partir de l'anàlisi de documents normatius I autors de dret civil I bioètica per qüestionar com s'efectua la manifestació de voluntat dels malalts mentals en la relació metge-pacient. Per a això, s'abordarà quins canvis van ocórrer en la capacitat civil en l'ordenament jurídic argentí. Després es discutirà la relació entre autonomia I competència I la seva configuració en la relació metge-pacient, per després endinsar-se en el consentiment dels malalts mentals. Finalment, es compararà el tractament donat a aquests individus als dos països


Asunto(s)
Humanos , Discapacidad Intelectual/epidemiología , Relaciones Médico-Paciente , Enfermos Mentales/legislación & jurisprudencia , Derechos Civiles , Consentimiento Informado/legislación & jurisprudencia , Argentina , Autonomía Personal , Competencia Clínica/legislación & jurisprudencia , Brasil
9.
Scand J Trauma Resusc Emerg Med ; 28(1): 51, 2020 Jun 08.
Artículo en Inglés | MEDLINE | ID: mdl-32513204

RESUMEN

BACKGROUND: Clinical research in severely ill or injured patients is required to improve healthcare but may be challenging to perform in practice. The aim of this study was to analyse barriers and challenges in the process of including critically ill patients in clinical studies. METHODS: Data from critically ill patients considered for inclusion in an observational study of venous thromboembolism in Norway were analysed. This included quantitative and qualitative information from the screening log, consent forms and research notes. RESULTS: Among 279 eligible critically ill patients, 204 (73%) were omitted from the study due to challenges and barriers in the inclusion process. Reasons for omission were categorised as practical in 133 (65%), medical in 31 (15%), and legal or ethical in 40 (20%) of the patients. Among 70 included patients, 29 (41%) consents were from patients and 41 (59%) from their next of kin. Several challenges were described herein; these included whether patients were competent to give consent, and which next of kin that should represent the patient. Furthermore, some included patients were unable to recall what they have consented, and some appeared unable to separate research from treatment. CONCLUSIONS: Barriers and challenges in the inclusion process led to the omission of near three out of four eligible patients. This analysis provided information about where the problem resides and may be solved. The majority of challenges among included patients were related to issues of autonomy and validity of consent. TRIAL REGISTRATION: ClinicalTrials.gov (NCT03405766).


Asunto(s)
Enfermedad Crítica/terapia , Dalteparina/uso terapéutico , Fibrinolíticos/uso terapéutico , Consentimiento Informado/ética , Consentimiento Informado/legislación & jurisprudencia , Selección de Paciente/ética , Adulto , Femenino , Humanos , Masculino , Noruega
10.
Bone Joint J ; 102-B(5): 550-555, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32349593

RESUMEN

The cost of clinical negligence in the UK has continued to rise despite no increase in claims numbers from 2016 to 2019. In the US, medical malpractice claim rates have fallen each year since 2001 and the payout rate has stabilized. In Germany, malpractice claim rates for spinal surgery fell yearly from 2012 to 2017, despite the number of spinal operations increasing. In Australia, public healthcare claim rates were largely static from 2008 to 2013, but private claims rose marginally. The cost of claims rose during the period. UK and Australian trends are therefore out of alignment with other international comparisons. Many of the claims in orthopaedics occur as a result of "failure to warn", i.e. lack of adequately documented and appropriate consent. The UK and USA have similar rates (26% and 24% respectively), but in Germany the rate is 14% and in Australia only 2%. This paper considers the drivers for the increased cost of clinical negligence claims in the UK compared to the USA, Germany and Australia, from a spinal and orthopaedic point of view, with a focus on "failure to warn" and lack of compliance with the principles established in February 2015 in the Supreme Court in the case of Montgomery v Lanarkshire Health Board. The article provides a description of the prevailing medicolegal situation in the UK and also calculates, from publicly available data, the cost to the public purse of the failure to comply with the principles established. It shows that compliance with the Montgomery principles would have an immediate and lasting positive impact on the sums paid by NHS Resolution to settle negligence cases in a way that has already been established in the USA. Cite this article: Bone Joint J 2020;102-B(5):550-555.


Asunto(s)
Consentimiento Informado/legislación & jurisprudencia , Mala Praxis/legislación & jurisprudencia , Procedimientos Ortopédicos/legislación & jurisprudencia , Medicina Estatal/legislación & jurisprudencia , Australia , Alemania , Humanos , Consentimiento Informado/ética , Medicina Estatal/ética , Decisiones de la Corte Suprema , Reino Unido , Estados Unidos
12.
N Z Med J ; 133(1515): 97-103, 2020 05 22.
Artículo en Inglés | MEDLINE | ID: mdl-32438381

RESUMEN

The role of the external clinical advisor is critical to the adjudication of complex claims in the processes of the Accident Compensation Corporation (ACC). This is particularly true of claims for treatment injury that occur during birth, which are often very complicated. In most cases external clinical advisors are non-treating doctors, whose opinion strongly guides the hand of ACC. This viewpoint considers the impact of the role of the external clinical advisor by using extracts from an external clinical advisor's report to show how a power imbalance can be enacted in ACC decision making processes. Also considered are the way that the normal checks and balances in the system, particularly those provided by the Health & Disability Commissioner, are bypassed in most cases. Finally, a recommendation is made to potential external clinical advisors to precisely following the standards set by the Medical Council in all cases when writing reports for ACC.


Asunto(s)
Traumatismos del Nacimiento/etiología , Compensación y Reparación/legislación & jurisprudencia , Testimonio de Experto/normas , Rol del Médico , Lesiones Encefálicas/etiología , Niño , Toma de Decisiones , Testimonio de Experto/legislación & jurisprudencia , Femenino , Trastornos del Crecimiento/complicaciones , Humanos , Enfermedad Iatrogénica , Recién Nacido , Consentimiento Informado/legislación & jurisprudencia , Masculino , Nueva Zelanda , Osteocondrodisplasias/complicaciones , Embarazo , Complicaciones del Embarazo/etiología
13.
Anaesthesia ; 75(9): 1229-1235, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32329902

RESUMEN

In the last decade, research in transplant medicine has focused on developing interventions in the management of the deceased organ donor to improve the quality and quantity of transplantable organs. Despite the promise of interventional donor research, there remain debates about the ethics of this research, specifically regarding gaining research consent. Here, we examine the concerns and ambiguities around consent for interventional donor research, which incorporate questions about who should consent for interventional donor research and what people are being asked to consent for. We highlight the US and UK policy responses to these concerns and argue that, whereas guidance in this area has done much to clarify these ambiguities, there is little consideration of the nature, practicalities and context around consent in this area, particularly regarding organ donors and their families. We review wider studies of consent in critical care research and social science studies of consent in medical research, to gain a broader view of consent in this area as a relational and contextual process. We contend a lack of consideration has been given to: what it might mean to consent to interventional donor research; how families, patients and health professionals might experience providing and seeking this consent; who is best placed to have these discussions; and the socio-institutional contexts affecting these processes. Further, empirical research is required to establish an ethical and sensitive model for consent in interventional donor research, ensuring the principles enshrined in research ethics are met and public trust in organ donation is maintained.


Asunto(s)
Investigación Biomédica/ética , Investigación Biomédica/legislación & jurisprudencia , Consentimiento Informado/ética , Consentimiento Informado/legislación & jurisprudencia , Donantes de Tejidos/ética , Donantes de Tejidos/legislación & jurisprudencia , Humanos , Reino Unido , Estados Unidos
17.
Clin Ter ; 171(2): e94-e96, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32141477

RESUMEN

End-of-life decisions are an emergent issue for bioethical debates and practical concerns among health professionals. On December 2017, Italy enacted a new law named "Rules about informed consent and advance directives", which promotes the relationship of care in a fiduciary sense through the implementation of a correct and exhaustive information. It is also prescribed to record in writing all the patients' decisions about consent or refusal. Furthermore, the law explicitly forbids unreasonable therapeutic obstinacy for terminal patient, legitimizing deep palliative sedation. Finally, the law establishes the use of "advance directives" as a written document by which adults and capable people can express their wishes regarding health treatments and diagnostic tests in anticipation of a possible future incapacity. The law provides that doctors must comply with these directives, unless they appear clearly incongruous or not corresponding to the patient's current clinical condition.


Asunto(s)
Directivas Anticipadas/legislación & jurisprudencia , Consentimiento Informado/legislación & jurisprudencia , Cuidado Terminal/legislación & jurisprudencia , Adulto , Toma de Decisiones , Humanos , Italia
18.
Georgian Med News ; (298): 175-180, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-32141874

RESUMEN

The purpose of this article is to analyze the main medical, legal, and ethical issues and challenges of euthanasia in the digital age. The methods that were used in this study are historical, logical, empirical, as well as comparative legal method for comparison of laws and practices of the EU and post-Soviet countries, including Ukraine. This choice determined by the fact that both groups of countries have common features and relations, while the features of their development affect approaches to regulating such sensitive and potentially open to abuse problems as euthanasia. There is no final legal answer as to whether to legalize, decriminalize or prohibit euthanasia in any of its forms. The features and legal terms of active and passive, voluntary and non-voluntary euthanasia and assisted suicide, especially for psychiatric and minor patients were researched, as well as conflicting arguments, which include individual autonomy, right to choose, the opportunity to get rid of suffering, as well as undermining the practice of palliative care, abuse in cases of vulnerable and dependent patients, moral burden on the doctors. The issue of control of the practice of euthanasia is complicated, given the extent to which it is possible to obtain informed consent, establish criteria for suffering and hopelessness, check the persistence, conviction and validity of requests for euthanasia, especially in the digital era. The potential legislation and judicial practice should provide for strict and effective guarantees, respect for the beliefs of each person and the right not to participate in any contentious practices, the balance of human rights and social values.


Asunto(s)
Eutanasia , Suicidio Asistido , Eutanasia/ética , Eutanasia/legislación & jurisprudencia , Humanos , Consentimiento Informado/legislación & jurisprudencia , Principios Morales , Cuidados Paliativos , Suicidio Asistido/ética , Suicidio Asistido/legislación & jurisprudencia , Ucrania
19.
G Ital Cardiol (Rome) ; 21(4): 306-308, 2020 Apr.
Artículo en Italiano | MEDLINE | ID: mdl-32202564

RESUMEN

The Italian law 219/2017, enacted on January 31, 2018, regulates patients' informed consent, personalized care planning and advance directives. The law provides for patient's self-determination in all phases of life. This also applies to patients suffering from chronic, progressive, terminal disease such as heart failure. In fact, the clinical and psychosocial trajectory for heart failure patients demands an interdisciplinary, systemic approach. Advance directives should be tailor-made to patient's needs and dynamically updated through the course of the disease according to patient's and family informed and shared decision-making. Healthcare professionals will require education and training to stay up to the task both clinically, psychologically and emotionally.


Asunto(s)
Directivas Anticipadas/legislación & jurisprudencia , Cuidadores , Consentimiento Informado/legislación & jurisprudencia , Órdenes de Resucitación , Toma de Decisiones , Humanos , Italia , Autonomía Personal , Cuidado Terminal
20.
Public Health ; 182: 51-52, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32171090

RESUMEN

OBJECTIVE: Informed consent (IC) principles are often overlooked aspects in debates about national screening programs. This short communication examines the Danish approach to IC in decision-making about screening participation. STUDY DESIGN: A descriptive approach is adopted in linking present screening practices with Danish regulation about IC and international ethical principles. METHODS: To ascertain the extent to which screening procedures come up to IC requirements, the article adopts a review approach by examining relevant Danish national legislation including ministerial orders as well as international ethical codes. RESULTS: The article finds that, although Danish legislation as well as international IC principles generally stipulates a decision-making process requiring oral communication, current procedures largely rely on one-way communication through written information available from leaflets, web sites, etc. Screening programs seem to have established no general formula to qualify healthcare users' understanding of data underlying their choice whether to be screened. CONCLUSION: The deviance from common IC principles may reduce healthcare quality, pose a safety problem, and challenge healthcare users' ability to exercise autonomy.


Asunto(s)
Comunicación , Toma de Decisiones , Consentimiento Informado/ética , Tamizaje Masivo , Participación del Paciente/psicología , Dinamarca , Humanos , Consentimiento Informado/legislación & jurisprudencia , Consentimiento Informado/psicología , Autonomía Personal , Calidad de la Atención de Salud
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...